AAAAAA

   
Results: 1-11 |
Results: 11
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN AN ANEPHRIC CHILD WITH MULTIPLY RECURRENT WILMS-TUMOR
Authors: DAGHER R KREISSMAN S ROBERTSON KA PROVISOR A BERGSTEIN J BURKE K RODMAN JH EMANUEL D SMITH FO
Citation: R. Dagher et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN AN ANEPHRIC CHILD WITH MULTIPLY RECURRENT WILMS-TUMOR, Journal of pediatric hematology/oncology, 20(4), 1998, pp. 357-360
PLATELET DEPLETION DURING PEDIATRIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HARVESTING
Authors: MCCARTHY L SMITH FO EMANUEL D ORAZI A DANIELSON C THOMPSON C THOMAS C KREISSMAN S
Citation: L. Mccarthy et al., PLATELET DEPLETION DURING PEDIATRIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HARVESTING, Transfusion science, 19(1), 1998, pp. 61-61
COMBINATION OF RHIL-11-CSF ENHANCES PLATELET (PLT) AND MYELOID RECOVERY FOLLOWING IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) CHEMOTHERAPYIN CHILDREN WITH SOLID TUMORS (ST) - RHIL-11 IS WELL TOLERATED AT DOUBLE THE ADULT RECOMMENDED DOSE(G)
Authors: GOLDMAN S DAVENPORT V REAMAN G LAVER J KREISSMAN S BLAZAR B BERG S KAYE J PATTERSON F CAIRO MS
Citation: S. Goldman et al., COMBINATION OF RHIL-11-CSF ENHANCES PLATELET (PLT) AND MYELOID RECOVERY FOLLOWING IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) CHEMOTHERAPYIN CHILDREN WITH SOLID TUMORS (ST) - RHIL-11 IS WELL TOLERATED AT DOUBLE THE ADULT RECOMMENDED DOSE(G), Experimental hematology, 25(8), 1997, pp. 201-201
AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOLLOWING MYELOABLATION WITH TOTAL-BODY IRRADIATION, MELPHALAN AND ETOPOSIDE FOR THE TREATMENT OF POOR-PROGNOSIS SOLID TUMORS IN CHILDREN AND ADULTS
Authors: EMANUEL D KREISSMAN S BREITFELD P ROBERTSON K LUCAS K SANDLER A CORNETTA K SMITH F
Citation: D. Emanuel et al., AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOLLOWING MYELOABLATION WITH TOTAL-BODY IRRADIATION, MELPHALAN AND ETOPOSIDE FOR THE TREATMENT OF POOR-PROGNOSIS SOLID TUMORS IN CHILDREN AND ADULTS, Blood, 90(10), 1997, pp. 4555-4555
RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(R)) IS TOLERATED AT DOUBLE THE ADULT DOSE AND ENHANCES HEMATOPOIETIC RECOVERY FOLLOWING IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY IN CHILDREN - CORRELATION WITH RAPID CLEARANCE, LACK OF INDUCTION OF INFLAMMATORY CYTOKINES AND MOBILIZATION OF EARLY PROGENITOR CELLS
Authors: KIROV I GOLDMAN S BLAZAR B VANDEVEN C DAVENPORT G REAMAN G LAVER J KREISSMAN S BERG S KAYE J PATTERSON F HUTABARAT R DYKSTRA K CAIRO MS
Citation: I. Kirov et al., RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(R)) IS TOLERATED AT DOUBLE THE ADULT DOSE AND ENHANCES HEMATOPOIETIC RECOVERY FOLLOWING IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) CHEMOTHERAPY IN CHILDREN - CORRELATION WITH RAPID CLEARANCE, LACK OF INDUCTION OF INFLAMMATORY CYTOKINES AND MOBILIZATION OF EARLY PROGENITOR CELLS, Blood, 90(10), 1997, pp. 2584-2584
ACCELERATED HEMATOPOIETIC RECOVERY WITH RHIL-11 FOLLOWING IFOSFAMIDE,CARBOPLATIN, AND ETOPOSIDE ADMINISTRATION IN CHILDREN WITH SOLID TUMOR OR LYMPHOMA - PRELIMINARY-RESULTS OF A PHASE I II TRIAL/
Authors: CAIRO MS DAVENPORT V REAMAN G LAVER J KREISSMAN S BLAZAR B BERG S PATTERSON F KAYE J
Citation: Ms. Cairo et al., ACCELERATED HEMATOPOIETIC RECOVERY WITH RHIL-11 FOLLOWING IFOSFAMIDE,CARBOPLATIN, AND ETOPOSIDE ADMINISTRATION IN CHILDREN WITH SOLID TUMOR OR LYMPHOMA - PRELIMINARY-RESULTS OF A PHASE I II TRIAL/, Experimental hematology, 24(9), 1996, pp. 432-432
COMING TO TERMS - PARENTS RESPONSE TO A FIRST CANCER RECURRENCE IN THEIR CHILD
Authors: HINDS PS BIRENBAUM LK CLARKESTEFFEN L QUARGNENTI A KREISSMAN S KAZAK A MEYER W MULHERN R PRATT C WILIMAS J
Citation: Ps. Hinds et al., COMING TO TERMS - PARENTS RESPONSE TO A FIRST CANCER RECURRENCE IN THEIR CHILD, Nursing research, 45(3), 1996, pp. 148-153
PLATELET DEPLETION DURING PEDIATRIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HARVESTING
Authors: MCCARTHY L SMITH FO EMANUEL D ORAZI A DANIELSON C THOMPSON C THOMAS C KREISSMAN S
Citation: L. Mccarthy et al., PLATELET DEPLETION DURING PEDIATRIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HARVESTING, Blood, 88(10), 1996, pp. 1586-1586
PRELIMINARY-RESULTS OF A PHASE I II STUDY OF RHIL-11 FOLLOWING IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) CHEMOTHERAPY IN PEDIATRIC-PATIENTS (PTS) WITH SOLID TUMORS (ST) OR LYMPHOMA (L) - ENHANCEMENT OF HEMATOLOGICAL RECONSTITUTION/
Authors: ALINAZIR A DAVENPORT V REAMAN G LAVER J KREISSMAN S BLAZAR B KAYE J PATTERSON F CAIRO MS
Citation: A. Alinazir et al., PRELIMINARY-RESULTS OF A PHASE I II STUDY OF RHIL-11 FOLLOWING IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) CHEMOTHERAPY IN PEDIATRIC-PATIENTS (PTS) WITH SOLID TUMORS (ST) OR LYMPHOMA (L) - ENHANCEMENT OF HEMATOLOGICAL RECONSTITUTION/, Blood, 86(10), 1995, pp. 2730-2730
USING BONE-MARROW (BM) IMMUNOCYTOCHEMICAL (ICC) ANALYSIS TO DETERMINEOPTIMAL TIMING OF PERIPHERAL-BLOOD STEM-CELL (PBSC) HARVEST FOR PATIENTS WITH BREAST-CANCER AND NEUROBLASTOMA
Authors: MOSS TJ CAIRO MS BOSTROM B KLETZEL M KREISSMAN S SENDER L COOPER B LAZARUS HM KENNEDY MJ MEAGHER R HERZIG RM ROSS AA
Citation: Tj. Moss et al., USING BONE-MARROW (BM) IMMUNOCYTOCHEMICAL (ICC) ANALYSIS TO DETERMINEOPTIMAL TIMING OF PERIPHERAL-BLOOD STEM-CELL (PBSC) HARVEST FOR PATIENTS WITH BREAST-CANCER AND NEUROBLASTOMA, Blood, 84(10), 1994, pp. 10000354-10000354
ANALYSIS OF 150 PEDIATRIC PERIPHERAL STEM-CELL PHERESIS CELL PRODUCTSOBTAINED FROM PEDIATRIC-PATIENTS UNDERGOING REPEATED CYCLES OF NON-MYELOABLATIVE HIGH-DOSE CHEMOTHERAPY - IMPLICATIONS FOR CD34+ PERIPHERALTRANSFUSIONS
Authors: SENDER L JAKACKI R MONTES V PATEL C KREISSMAN S BERTOLONE S
Citation: L. Sender et al., ANALYSIS OF 150 PEDIATRIC PERIPHERAL STEM-CELL PHERESIS CELL PRODUCTSOBTAINED FROM PEDIATRIC-PATIENTS UNDERGOING REPEATED CYCLES OF NON-MYELOABLATIVE HIGH-DOSE CHEMOTHERAPY - IMPLICATIONS FOR CD34+ PERIPHERALTRANSFUSIONS, Blood, 82(10), 1993, pp. 10000641-10000641
Risultati: 1-11 |